WallStreetZenWallStreetZen

NASDAQ: VKTX
Viking Therapeutics Inc Stock Ownership - Who owns Viking Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Viking Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Brian LianPresident CEO2025-07-0326,889$27.80
$747.62kSell
Greg ZanteChief Financial Officer2025-07-034,266$27.76
$118.43kSell
Marianna ManciniChief Operating Officer2025-07-034,266$27.77
$118.47kSell
Matthew W. FoehrDirector2025-04-1120,786$8.00
$166.29kBuy
Sarah Kathryn RouanDirector2025-03-311,240$24.15
$29.94kBuy
Sarah Kathryn RouanDirector2025-03-311,240$24.15
$29.94kBuy
Sarah Kathryn RouanDirector2025-03-311,240$24.15
$29.94kBuy
Marianna ManciniChief Operating Officer2025-01-065,100$43.32
$220.91kSell
Brian LianPresident CEO2025-01-0619,000$43.32
$823.02kSell
Brian LianPresident CEO2025-01-06175,490$42.68
$7.49MSell

1 of 4

VKTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VKTX insiders and whales buy or sell their stock.

VKTX Shareholders

What type of owners hold Viking Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc9.04%10,162,632$319.31MInstitution
Fmr LLC8.73%9,821,897$308.60MInstitution
Ligand Pharmaceuticals Inc5.18%5,819,383$182.85MInsider
Blackrock Inc4.84%5,437,508$170.85MInstitution
State Street Corp3.36%3,775,691$118.63MInstitution
Morgan Stanley2.89%3,247,694$102.04MInstitution
Jpmorgan Chase Co2.35%2,639,055$82.92MInstitution
Brian Lian2.12%2,388,014$75.03MInsider
Susquehanna International Group LLP1.84%2,066,651$64.93MInstitution
Geode Capital Management LLC1.71%1,923,305$60.43MInstitution

1 of 3

VKTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VKTX67.38%8.93%Net Selling
CRNX89.09%10.91%Net BuyingNet Selling
PRAX63.26%36.74%Net SellingNet Selling
TLX0.14%0.00%
ADMA79.04%20.96%Net SellingNet Selling
View Top Biotech Stocks

Viking Therapeutics Stock Ownership FAQ

Who owns Viking Therapeutics?

Viking Therapeutics (NASDAQ: VKTX) is owned by 67.38% institutional shareholders, 8.93% Viking Therapeutics insiders, and 23.69% retail investors. Ligand Pharmaceuticals Inc is the largest individual Viking Therapeutics shareholder, owning 5.82M shares representing 5.15% of the company. Ligand Pharmaceuticals Inc's Viking Therapeutics shares are currently valued at $197.39M.

If you're new to stock investing, here's how to buy Viking Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.